Stellenbosch University Immunology Research Group
Publications
2015
1. Jones C E, Hesseling A C, Tena-Coki N G, Scriba T J, Chegou N N, Kidd M, Wilkinson R J and Kampmann B. The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination. AIDS (2015) 29:155-165.
http://www.ncbi.nlm.nih.gov/pubmed/25535752
2. Visser D H, Solomons R S, Ronacher K, van Well G T, Heymans M W, Walzl G, Chegou N N, Schoeman J F and van Furth A M.Host immune response to tuberculous meningitis. Clin. Infect. Dis. (2015) 60:177-187.
http://www.ncbi.nlm.nih.gov/pubmed/25301213
3. Mandalakas A M, Kirchner H L, Walzl G, R P, Schaaf H S, Cotton M F, Grewal H M S, and Hesseling A C. Optimizing the Detection of Recent Tuberculosis Infection in Children in a High TB-HIV Burden Setting. Am J Respir Crit Care Med (2015)191(7):820-30.
http://www.ncbi.nlm.nih.gov/pubmed/25622087
4. Fang Z, van der Merwe R G, Warren R M, Schubert W-D, Gey van Pittius N C. Assessing the progress of Mycobacterium tuberculosis H37Rv structural genomics. Tuberculosis (2015) 95(2):131–6.
http://www.tuberculosisjournal.com/article/S1472-9792(14)20539-7/pdf
5. Fang Z, Sampson S L, Warren R M, Gey van Pittius N C, Newton-Foot M. Iron acquisition strategies in mycobacteria. Tuberculosis (2015) 95(2):123–30.
http://www.ncbi.nlm.nih.gov/pubmed/25578513
6. Axelsson-Robertson R, Rao M, Loxton AG, Walzl G, Bates M, Zumla A, Maeurer M. Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment. Int J Infect Dis (2015) 32:23-9.
http://www.ncbi.nlm.nih.gov/pubmed/25809751
7. Ronacher K, Joosten S, van Crevel R, Dockrell, H, Walzl G, Ottenhoff T. Acquired immunodeficiencies and tuberculosis: Focus on HIV/AIDS and Diabetes Mellitus. Immunological Reviews (2015) 264(1):121-37.
http://www.ncbi.nlm.nih.gov/pubmed/25703556
8. Hesseling AC, Jaspan H B, Black GF, Nene N, Walzl G. Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination. Int J Tuberc Lung Dis (2015) 19(4):454-62.
http://www.ncbi.nlm.nih.gov/pubmed/25860002
9. Masson L, Passmore J A, Liebenberg L J, Werner L, Baxter C, Arnold K B, Williamson C, Little F, Mansoor L E, Naranbhai V, Lauffenburger D A, Ronacher K, Walzl G, Garrett N J, Williams B L, Couto-Rodriguez M, Hornig M, Lipkin W I, Grobler A, Karim Q A, Karim S S. Genital Inflammation and the Risk of HIV Acquisition in Women. Clin Infect Dis (2015)61(2):260-9.
http://www.ncbi.nlm.nih.gov/pubmed/25900168
10. Van Rensburg I C, Loxton A G. Transcriptomics: the key to biomarker discovery during tuberculosis? Biomark Med (2015)9(5):483-95.
http://www.ncbi.nlm.nih.gov/pubmed/25985177
11. Masson L, Salkinder A L, Olivier A J, McKinnon L R, Gamieldien H, Mlisana K, Scriba T J, Lewis D A, Little F, Jaspan H B, Ronacher K, Denny L, Abdool Karim S S, Passmore J S. Relationship between female genital tract infections, mucosal interleukin-17 production and local T helper type 17 cells. Immunology (2015). [In press]
http://www.ncbi.nlm.nih.gov/pubmed/26302175
12. Corstjens P L, Tjon Kon Fat E M, de Dood C J, van der Ploeg-van Schip J J, Franken K L, Chegou N N, Sutherland J S, Howe R, Mihret A, Kassa D, van der Vyver M, Sheehama J, Simukonda F, Mayanja-Kizza H, Ottenhoff T H, Walzl G, Geluk A; AE-TBC consortium. Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa. Clin Biochem (2015). [In press]
http://www.ncbi.nlm.nih.gov/pubmed/26285074
13. Baumann R, Kaempfer S, Chegou N N, Oehlmann W, Spallek R, Loxton A G, van HeldenP D, Black G F, Singh M, Walzl G. A subgroup of latently Mycobacterium tuberculosis infected individuals is characterized by consistently elevated IgA responses to several Mycobacterial antigens. Mediators Inflamm (2015). [In press]
http://www.ncbi.nlm.nih.gov/pubmed/26347586
14.Esterhuyse MM, Weiner J 3rd, Caron E, Loxton AG, Iannaccone M, Wagman C, Saikali P, Stanley K, Wolski WE, Mollenkopf HJ, Schick M, Aebersold R, Linhart H, Walzl G, Kaufmann SH. Epigenetics and proteomics join transcriptomics in the quest for tuberculosis biomarkers. MBio (2015) 6(5).
http://www.ncbi.nlm.nih.gov/pubmed/26347586
15. Cliff J M, Cho J E, Lee J S, Ronacher K, King E C, van Helden P, Walzl G, Dockrell, H M. Excessive cytolytic responses predict tuberculosis relapse after apparently successful treatment. J Infect Dis. 2015. [In press]
http://www.ncbi.nlm.nih.gov/pubmed/26351358
16. Nicol M P, Gnanashanmugam D, Browning R, Click E S, Cuevas L E, Detjen A, Graham S M, Levin M, Makhene M, Nahid P, Perez-Velez C M, Reither K, Song R, Spiegel H M, Worrell C, Zar H J, Walzl G. A blueprint to address research gaps in the development of biomarkers for pediatric tuberculosis. Clin Infect Dis 2015 61(3):164-72.
http://www.ncbi.nlm.nih.gov/pubmed/26409279
17. Kriel M, Lotz J W, Kidd M, Walzl G. Evaluation of a radiological severity score to predict treatment outcome in adults with pulmonary tuberculosis. Int J Tuberc Lung Dis 2015 19(11):1354-60.
http://www.ncbi.nlm.nih.gov/pubmed/26467588
18. Du Plessis WJ, Walzl G, Loxton AG. B cells as multi-functional players during Mycobacterium tuberculosis infection and disease. Tuberculosis. (2015) 15:1-8.
http://www.ncbi.nlm.nih.gov/pubmed/26611659